Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Australian (ASX) Healthtech Industry Analysis

UpdatedMay 30, 2026
DataAggregated Company Financials
Companies18
  • 7D3.0%
  • 3M2.2%
  • 1Y-48.7%
  • YTDn/a

The Healthtech industry is up 3.0% in the last week, with Pro Medicus up 3.4%. In the past year, the industry is down 49%. Looking forward, earnings are forecast to grow by 5.3% annually.

Industry Valuation and Performance

Has the Australian Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 30 May 2026AU$15.7bAU$608.7mAU$93.8m33.1x167.8x25.9x
Mon, 27 Apr 2026AU$16.2bAU$609.5mAU$93.7m32.9x173x26.6x
Wed, 25 Mar 2026AU$14.0bAU$613.3mAU$93.3m28.8x149.5x22.7x
Fri, 20 Feb 2026AU$17.3bAU$488.7mAU$124.3m49x139.3x35.4x
Sun, 18 Jan 2026AU$26.0bAU$465.1mAU$2.1m75.5x12189.8x55.9x
Tue, 16 Dec 2025AU$27.6bAU$465.9mAU$1.7m67.3x16357x59.2x
Thu, 13 Nov 2025AU$29.5bAU$467.4mAU$1.5m65.1x19869x63.2x
Sat, 11 Oct 2025AU$34.6bAU$467.2mAU$1.6m61.4x22136.5x74.1x
Mon, 08 Sep 2025AU$33.2bAU$467.5mAU$1.3m63.9x25919.1x71x
Wed, 06 Aug 2025AU$34.4bAU$526.9m-AU$41,902,418.08180.1x-821.7x65.3x
Fri, 04 Jul 2025AU$33.4bAU$525.6m-AU$41,760,739.35175.8x-800.2x63.6x
Sun, 01 Jun 2025AU$30.8bAU$526.8m-AU$41,646,146.84159.5x-738.5x58.4x
Tue, 29 Apr 2025AU$24.0bAU$527.5m-AU$41,888,465.82126.1x-573.8x45.6x
Thu, 27 Mar 2025AU$25.3bAU$528.0m-AU$41,407,863.43131.5x-610.7x47.9x
Sat, 22 Feb 2025AU$31.3bAU$614.9m-AU$42,768,197.39115x-732.7x51x
Mon, 20 Jan 2025AU$27.3bAU$586.4m-AU$64,026,111.69149.8x-426.8x46.6x
Wed, 18 Dec 2024AU$28.2bAU$586.3m-AU$63,896,655.55201.8x-440.6x48x
Fri, 15 Nov 2024AU$22.6bAU$583.2m-AU$63,165,821.45201.8x-357.4x38.7x
Sun, 13 Oct 2024AU$20.8bAU$579.0m-AU$62,279,154.08235.1x-334x35.9x
Tue, 10 Sep 2024AU$17.7bAU$582.3m-AU$62,945,756.03198.8x-281.3x30.4x
Thu, 08 Aug 2024AU$14.4bAU$535.4m-AU$82,487,029.76105x-174.2x26.8x
Sat, 06 Jul 2024AU$15.1bAU$531.9m-AU$81,324,118.54109.6x-185.3x28.3x
Mon, 03 Jun 2024AU$14.0bAU$533.5m-AU$81,855,215.80102.7x-170.5x26.2x
Wed, 01 May 2024AU$13.3bAU$569.6m-AU$90,396,927.3297.7x-147.2x23.4x
Fri, 29 Mar 2024AU$12.5bAU$572.0m-AU$103,120,950.7991.3x-121.5x21.9x
Sun, 25 Feb 2024AU$11.9bAU$547.2m-AU$122,817,689.0785.9x-97x21.8x
Tue, 23 Jan 2024AU$12.3bAU$529.8m-AU$141,009,004.00105.9x-87.2x23.2x
Thu, 21 Dec 2023AU$11.6bAU$524.8m-AU$106,034,599.00103.5x-109.2x22.1x
Sat, 18 Nov 2023AU$10.7bAU$526.2m-AU$107,761,438.0098.1x-99.6x20.4x
Mon, 16 Oct 2023AU$10.3bAU$529.2m-AU$107,944,324.0093.5x-95.7x19.5x
Wed, 13 Sep 2023AU$9.2bAU$529.1m-AU$113,313,029.0086.2x-81.4x17.4x
Fri, 11 Aug 2023AU$9.1bAU$502.7m-AU$154,056,319.0095.6x-58.8x18x
Sun, 09 Jul 2023AU$8.4bAU$500.5m-AU$153,164,093.0090.4x-54.6x16.7x
Tue, 06 Jun 2023AU$8.4bAU$499.7m-AU$151,951,465.0095.1x-55.6x16.9x
Price to Earnings Ratio

-55.6x


Total Market Cap: AU$8.4bTotal Earnings: -AU$151,951,465.00Total Revenue: AU$499.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Healthtech Industry Price to Earnings3Y Average 2460.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Australian Health Care Technology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 168x which is lower than its 3-year average PE of 2kx.
  • The 3-year average PS ratio of 37.5x is higher than the industry's current PS ratio of 25.9x.
Past Earnings Growth
  • Total earnings for the Health Care Technology industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 6.8% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Australian Healthtech compare with similar industries?

AU Market0.98%
Healthcare0.17%
Healthtech3.00%
Healthtech3.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PME Pro MedicusAU$132.263.4%
+AU$450.3m		-53.1%PE58.9x
4DX 4DMedicalAU$3.979.7%
+AU$207.5m		1,067.6%PS405x
AYA ArtryaAU$4.954.4%
+AU$33.6m		551.3%PS27276.1x
ONE Oneview HealthcareAU$0.185.9%
+AU$8.4m		-32.1%PS7.7x
BMT Beamtree HoldingsAU$0.0966.7%
+AU$1.7m		-66.3%PS1x

Latest News

M7T
AU$0.33
Mach7 Technologies
7D
1.5%
1Y
-10.8%
ALC
AU$0.11
Alcidion Group
7D
-2.3%
1Y
25.0%
DOC
AU$0.14
Doctor Care Anywhere Group
7D
-6.9%
1Y
28.6%
CGS
AU$2.55
Cogstate
7D
-2.7%
1Y
95.4%
Narrative Update • May 21

CGS: Lower Discount Rate And Solid Margins Will Support Future Upside

Analysts have adjusted their price target for Cogstate to A$3.18, reflecting updated assumptions around discount rates and P/E multiples, while keeping revenue growth and profit margin expectations broadly in line with prior estimates. Valuation Changes Fair Value: A$3.18 remains unchanged, with no adjustment to the underlying fair value estimate.
SHG
AU$0.20
Singular Health Group
7D
-2.5%
1Y
-35.0%
Analysis Article • May 20

Is Singular Health Group (ASX:SHG) In A Good Position To Invest In Growth?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
ONE
AU$0.18
Oneview Healthcare
7D
5.9%
1Y
-32.1%
PME
AU$132.26
Pro Medicus
7D
3.4%
1Y
-53.1%
4DX
AU$3.97
4DMedical
7D
9.7%
1Y
1,067.6%
Narrative Update • May 15

4DX: Index Inclusion And European Certification Will Test Elevated Future Earnings Multiple

Analysts have modestly adjusted their price target for 4DMedical to A$4.47, reflecting updated assumptions around a slightly lower discount rate, a very large revenue growth outlook, and a broadly unchanged long term profit margin and future P/E multiple. What's in the News 4DMedical entered a one year contractual engagement with GlaxoSmithKline, in association with Flywheel Exchange, to provide its quantitative lung imaging analytics for pulmonary drug development and clinical research, with commercial terms confidential and described as not individually material (Client Announcements).
BMT
AU$0.096
Beamtree Holdings
7D
6.7%
1Y
-66.3%
TRI
AU$0.025
TrivarX
7D
-13.8%
1Y
92.3%
Analysis Article • May 06

We're Keeping An Eye On TrivarX's (ASX:TRI) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
BB1
AU$0.66
BlinkLab
7D
-8.3%
1Y
61.0%
AYA
AU$4.95
Artrya
7D
4.4%
1Y
551.3%
HIQ
AU$0.008
HITIQ
7D
-20.0%
1Y
-57.9%
TD1
AU$0.057
TALi Digital
7D
11.8%
1Y
-43.0%
ADR
AU$0.002
Adherium
7D
-20.0%
1Y
-71.4%